Peptides DB
Research-centric peptide and protocol reference hub
Study 3 of 22KPV literaturePubMed · Review2025

Challenges in clinical nutrition research in Latin America: A narrative review.

Not reported in abstract.

Read at PubMedAdd to compare

Where it sits

this study against the rest of the kpv corpus
2
Preclinical
14
Observational
0
Open-label
3
Randomised
3
Reviews · this one

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2025

Abstract

The authors’ words, as PubMed supplied them

Conducting high-quality clinical research requires collaborative, interdisciplinary efforts, sustained institutional leadership, and adequate financial support - resources that are unfortunately insufficient across much of Latin America. This situation is no different in the field of clinical nutrition, where both practice and research face similar structural limitations. Medical nutrition therapy is a critical therapeutic modality for many patients, particularly given the high prevalence of disease-related malnutrition (DRM), especially in hospital settings across the world. This condition significantly compromises patient outcomes and imposes a substantial financial burden on already strained healthcare systems. Despite the urgency of the issue, early identification and effective nutritional management are often hampered by the absence of cost-effective, evidence-based policies. The development and implementation of such policies depend on robust clinical research, which remains underdeveloped in the region. This narrative review examines the current landscape of clinical nutrition research and highlights key barriers to its advancement, and presents practical strategies to overcome these challenges. Furthermore, it showcases successful regional initiatives and outlines future opportunities to strengthen the field, ultimately aiming to foster meaningful progress in clinical nutrition research and practice.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.
  • Not reported in abstract.
  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Not reported in abstract.

Elsewhere in the KPV corpus

CCritical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.Cellular and molecular gastroenterology and hepatology · 2016 · Not reported in abstract.AnimalBCauses and timing of death in extremely premature infants from 2000 through 2011.The New England journal of medicine · 2015 · 275 deaths per 1000 live births from 2000 through 2003, 95% CI 264 to 285.HumanAHydrocortisone to Improve Survival without Bronchopulmonary Dysplasia.The New England journal of medicine · 2022 · Survival without moderate or severe bronchopulmonary dysplasia at 36 weeks was 16.6% in the hydrocortisone group and 13.2% in the placebo group.HumanATrial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.The New England journal of medicine · 2022 · Incidence of death or neurodevelopmental impairment was 52.5% in the erythropoietin group and 49.5% in the placebo group, relative risk 1.03, 95% CI 0.86 to 1.24, P=0.74.HumanCMaternal potassium-magnesium sulfate supplementation in low-protein diets improves performance and health of sows and suckling piglets.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026 · n=120 · Weaning-to-estrus interval decreased linearly with increasing PMS supplementation, p=0.022.AnimalCDissecting the evolutionary forces shaping codon usage bias in SFTSV from eastern China: Insights from a previously underrepresented region.Virulence · 2026 · n=152 · Natural selection accounted for 52.8-91.4% of codon usage bias.In vitro